<SEC-DOCUMENT>0001193125-16-723566-index.html : 20160928 <SEC-HEADER>0001193125-16-723566.hdr.sgml : 20160928 <ACCEPTANCE-DATETIME>20160928161655 ACCESSION NUMBER: 0001193125-16-723566 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20160928 DATE AS OF CHANGE: 20160928 GROUP MEMBERS: CLAIRMARK INVESTMENTS LTD. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 252025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-87951 FILM NUMBER: 161907121 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-9911 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DAN LESLIE CENTRAL INDEX KEY: 0001180551 FILING VALUES: FORM TYPE: SC 13D MAIL ADDRESS: STREET 1: C/O ELEVEN BIOTHERAPEUTICS STREET 2: 215 FIRST ST. #400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13D <SEQUENCE>1 <FILENAME>d270441dsc13d.htm <DESCRIPTION>SC 13D <TEXT> Document 1 - file: d270441dsc13d.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>d270441dex991.htm <DESCRIPTION>EX-99.1 <TEXT> Document 2 - file: d270441dex991.htm
</DOCUMENT> </SEC-DOCUMENT>